combination of a compound, compound of formula i or a pharmaceutically acceptable salt thereof, use, kit, product, method for treating a hyperproliferative disorder and method for treating an akt kinase-modulated disease or condition in a mammal
The invention provides combinations comprising a) compound of formula I: (formula I), or a pharmaceutically acceptable salt thereof； and another agent selected from GDC-0973, PD-0325901, or a pharmaceutically acceptable salt thereof. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
